Riskpilot← Back to searchSign inGet full accessFALKUM APOTEK AS
ASActiveOrg 925183733Århusvegen 33, 3723 SkienRetail sale of pharmaceutical products · NACE 4773Est. 202013 employees
Revenue 2023
NOK 19,3M
+17% vs 2022
EBITDA margin
6.3%
+130% vs 2022
Equity ratio
9.7%
Financial strength
Net profit 2023
NOK 748K
+276% vs 2022
| Revenue | NOK 19,3M | +17% |
| EBITDA | NOK 1,2M | +130% |
| Net profit | NOK 748K | +276% |
| Total assets | NOK 6,2M | +69% |
| Equity | NOK 601K | +0% |
| Employees | 13 | — |
Legal name
FALKUM APOTEK AS
Org number
925183733
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
11. juni 2020
Share capital
NOK 600 000
Employees
13 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Eie og drive apotek og alt hva hermed står i forbindelse.
Address
Århusvegen 33, 3723 Skien
Phone
+4733291100
Email
falkum@vitusapotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenue | 3 740 | 12 995 | 16 507 | 19 307 |
| Staff expenses | −1 294 | −2 630 | −4 147 | −3 807 |
| EBITDA | −266 | 551 | 533 | 1 226 |
| Depreciation & amort. | −69 | −213 | −229 | −232 |
| EBIT | −335 | 338 | 304 | 994 |
| Net financials | −37 | −68 | −49 | −14 |
| Profit before tax | −372 | 270 | 255 | 979 |
| Tax | −84 | 59 | 56 | 231 |
| Net profit | −288 | 210 | 199 | 748 |
| Item | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Total assets | 4 530 | 5 002 | 3 678 | 6 202 |
| Equity | 303 | 513 | 602 | 601 |
| Long-term debt | 1 680 | 1 320 | 645 | 0 |
| Short-term debt | 2 547 | 3 168 | 2 431 | 5 601 |
| Total debt | 4 227 | 4 488 | 3 076 | 5 601 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202023
Equity ratio
9.7%
This company
38.2%
Market median
-75% vs market
20202023
Return on equity
124.6%
This company
18.4%
Market median
+577% vs market
20202023
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20202023
Asset turnover
3.11×
This company
1.12×
Market median
+178% vs market
20202023
Debt / equity
9.33×
This company
0.62×
Market median
-1405% vs market
20202023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Apoinvest Holding As
FALKUM APOTEK AS Board members of FALKUM APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Brekke | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |
| Gulzeb Aziz | Board of Directors | 0 companies |